Nectar Lifesciences Limited (LUX: NECLF)
Luxembourg flag Luxembourg · Delayed Price · Currency is EUR · Price in USD
0.394
+0.006 (1.55%)
At close: Nov 27, 2024

Nectar Lifesciences Revenue

Nectar Lifesciences had revenue of 4.28B INR in the quarter ending September 30, 2024, with 7.52% growth. This brings the company's revenue in the last twelve months to 16.79B, up 10.18% year-over-year. In the fiscal year ending March 31, 2024, Nectar Lifesciences had annual revenue of 16.85B with 10.56% growth.

Revenue (ttm)
16.79B INR
Revenue Growth
+10.18%
P/S Ratio
n/a
Revenue / Employee
9.96M INR
Employees
1,686
Market Cap
101.72M EUR

Revenue Chart

* This company reports financials in INR.

History

Fiscal Year End Revenue Change Growth
Mar 31, 202416.85B1.61B10.56%
Mar 31, 202315.24B-1.45B-8.70%
Mar 31, 202216.69B1.26B8.13%
Mar 31, 202115.43B-8.23B-34.78%
Mar 31, 202023.66B-4.16B-14.97%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition